At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 60 enrolled
Drug / intervention
Prednisone +2 moredrug
Likely dose
Prednisone 60mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Use of Oral Steroids Before Circumferential Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation to Improve Outcomes
In Brief
A Phase 4 clinical trial evaluating Prednisone, Placebo, and 1 other intervention for Atrial Fibrillation. Completed, enrolled 60 participants across 1 site.
Detailed Summary
The primary purpose of this study is to assess the efficacy of oral prednisone in improving the outcomes of pulmonary vein isolation with radiofrequency ablation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2010
First PostedSep 2010
Primary CompletionDec 2013
TodayJul 2026
First PostedSep 21, 2010
Enrollment StartSep 1, 2010
Primary CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 15.8 years ago
Interventions
Prednisonedrug
60mg of oral prednisone 2 days before procedure, day of procedure, and 1 day after procedure
Placeboother
60mg placebo pill given 2 days before procedure, day of procedure, and 1 day after procedure
Ablation Procedureprocedure
Atrial Fibrillation (AF) ablation